Anti-P3H3/ GRCB/ HSU47926 functional antibody
Anti-P3H3/ GRCB/ HSU47926 functional antibody for cell culture, ELISA & in-vivo assay
Go to P3H3/P3H3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE0597-Ab-1/ GM-Tg-hg-SE0597-Ab-2 | Anti-Human P3H3 monoclonal antibody | Human |
GM-Tg-rg-SE0597-Ab-1/ GM-Tg-rg-SE0597-Ab-2 | Anti-Rat P3H3 monoclonal antibody | Rat |
GM-Tg-mg-SE0597-Ab-1/ GM-Tg-mg-SE0597-Ab-2 | Anti-Mouse P3H3 monoclonal antibody | Mouse |
GM-Tg-cynog-SE0597-Ab-1/ GM-Tg-cynog-SE0597-Ab-2 | Anti-Cynomolgus/ Rhesus macaque P3H3 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE0597-Ab-1/ GM-Tg-felg-SE0597-Ab-2 | Anti-Feline P3H3 monoclonal antibody | Feline |
GM-Tg-cang-SE0597-Ab-1/ GM-Tg-cang-SE0597-Ab-2 | Anti-Canine P3H3 monoclonal antibody | Canine |
GM-Tg-bovg-SE0597-Ab-1/ GM-Tg-bovg-SE0597-Ab-2 | Anti-Bovine P3H3 monoclonal antibody | Bovine |
GM-Tg-equg-SE0597-Ab-1/ GM-Tg-equg-SE0597-Ab-2 | Anti-Equine P3H3 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE0597-Ab-1/ GM-Tg-hg-SE0597-Ab-2; GM-Tg-rg-SE0597-Ab-1/ GM-Tg-rg-SE0597-Ab-2; GM-Tg-mg-SE0597-Ab-1/ GM-Tg-mg-SE0597-Ab-2; GM-Tg-cynog-SE0597-Ab-1/ GM-Tg-cynog-SE0597-Ab-2; GM-Tg-felg-SE0597-Ab-1/ GM-Tg-felg-SE0597-Ab-2; GM-Tg-cang-SE0597-Ab-1/ GM-Tg-cang-SE0597-Ab-2; GM-Tg-bovg-SE0597-Ab-1/ GM-Tg-bovg-SE0597-Ab-2; GM-Tg-equg-SE0597-Ab-1/ GM-Tg-equg-SE0597-Ab-2 |
Products Name | Anti-P3H3 monoclonal antibody |
Format | mab |
Target Name | P3H3 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-P3H3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE0597-Ag-1 | Recombinant multi-species P3H3/ GRCB/ HSU47926 protein |
Target information
Target ID | GM-SE0597 |
Target Name | P3H3 |
Gene ID | 10536,14789,297595,713865,100686626,101093365,100060032 |
Gene Symbol and Synonyms | GRCB,HSU47926,LEPREL2,P3H3 |
Uniprot Accession | Q8IVL6 |
Uniprot Entry Name | P3H3_HUMAN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000110811 |
Target Classification | N/A |
The target: P3H3, gene name: P3H3, also named as GRCB, HSU47926, LEPREL2. The protein encoded by this gene belongs to the leprecan family of proteoglycans, which function as collagen prolyl hydroxylases that are required for proper collagen biosynthesis, folding and assembly. This protein, like other family members, is thought to reside in the endoplasmic reticulum. Epigenetic inactivation of this gene is associated with breast and other cancers, suggesting that it may function as a tumor suppressor. [provided by RefSeq, Aug 2013].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.